Ahrens Brenton Karl (CIK 0001322927)

Latest company ownership

Shares held
29,125
Last filed at
Dec 28, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 16, 2022 Sep 20, 2022 Iterum Therapeutics plc Director Sell 22.5 -37,246 -98.91% $67.9K
Sep 13, 2022 Sep 15, 2022 Iterum Therapeutics plc Director Sell 22.5 -45,000 -54.44% $93.8K
Sep 8, 2022 Sep 12, 2022 Iterum Therapeutics plc Director Sell 22.5 -33,298 -28.72% $76.8K
May 30, 2018 May 30, 2018 Iterum Therapeutics plc Director Buy 100.0 +506,656 41.31% $6.6M